These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 32566906)

  • 1. Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.
    Baral B; Mozafari MR
    ACS Pharmacol Transl Sci; 2020 Jun; 3(3):373-400. PubMed ID: 32566906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic drug discovery: Challenges and perspectives in the light of emerging antibiotic resistance.
    Bhattarai K; Bastola R; Baral B
    Adv Genet; 2020; 105():229-292. PubMed ID: 32560788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.
    Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG
    Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative 'superbugs'.
    Schneider EK; Reyes-Ortega F; Velkov T; Li J
    Essays Biochem; 2017 Feb; 61(1):115-125. PubMed ID: 28258235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation microbial drugs developed from microbiome's natural products.
    Bhattarai K; Bhattarai K; Baral B
    Adv Genet; 2021; 108():341-382. PubMed ID: 34844715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterials as multimodal photothermal agents (PTAs) against 'Superbugs'.
    Roy S; Roy J; Guo B
    J Mater Chem B; 2023 Mar; 11(11):2287-2306. PubMed ID: 36857688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing to overcome microbial resistance.
    Jampilek J
    Drug Discov Today; 2022 Jul; 27(7):2028-2041. PubMed ID: 35561965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal.
    Saeed U; Insaf RA; Piracha ZZ; Tariq MN; Sohail A; Abbasi UA; Fida Rana MS; Gilani SS; Noor S; Noor E; Waheed Y; Wahid M; Najmi MH; Fazal I
    Front Microbiol; 2023; 14():1270018. PubMed ID: 38098671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review.
    Parmanik A; Das S; Kar B; Bose A; Dwivedi GR; Pandey MM
    Curr Microbiol; 2022 Nov; 79(12):388. PubMed ID: 36329256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
    Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
    Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision.
    Mitra S; Sultana SA; Prova SR; Uddin TM; Islam F; Das R; Nainu F; Sartini S; Chidambaram K; Alhumaydhi FA; Emran TB; Simal-Gandara J
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1309-1332. PubMed ID: 36069241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance.
    Chen L; Kumar S; Wu H
    Arch Microbiol; 2023 Oct; 205(11):356. PubMed ID: 37863957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescuing the Last-Line Polymyxins: Achievements and Challenges.
    Nang SC; Azad MAK; Velkov T; Zhou QT; Li J
    Pharmacol Rev; 2021 Apr; 73(2):679-728. PubMed ID: 33627412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review.
    Muteeb G; Rehman MT; Shahwan M; Aatif M
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Human Host Defense Antimicrobial Peptide-Conjugated Biochar Nanocomposites for Combating Broad-Spectrum Superbugs.
    Gao Y; Pramanik A; Patibandla S; Gates K; Hill G; Ignatius A; Ray PC
    ACS Appl Bio Mater; 2020 Nov; 3(11):7696-7705. PubMed ID: 35019509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption.
    Limmathurotsakul D; Sandoe JAT; Barrett DC; Corley M; Hsu LY; Mendelson M; Collignon P; Laxminarayan R; Peacock SJ; Howard P
    J Antimicrob Chemother; 2019 Aug; 74(8):2122-2127. PubMed ID: 31074489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
    Lewies A; Du Plessis LH; Wentzel JF
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.
    Holbein BE; Ang MTC; Allan DS; Chen W; Lehmann C
    Environ Chem Lett; 2021; 19(4):2789-2808. PubMed ID: 33907538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.